A new microneedle patch could offer an easier way to deliver a vaccine for measles, a disease that killed nearly 140,000 children in 2010.
“We showed in this study that measles vaccine delivered using a microneedle patch produced an immune response that is indistinguishable from the response produced when the vaccine is delivered subcutaneously,” says Chris Edens, the study’s first author and a graduate student at the Georgia Institute of Technology and Emory University.
Full story at Futurity.
More research news from top universities.
Photo credit: Gary Meek/Georgia Tech